Kovai Medical Center and Hospital Limited (BOM: 523323)
India
· Delayed Price · Currency is INR 5,487.80
+101.35 (1.88%)
At close: Sep 10, 2024
Kovai Medical Center and Hospital Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 12,601 | 12,196 | 10,197 | 9,053 | 6,904 | 7,117 | Upgrade
|
| Revenue Growth (YoY) | 19.06% | 19.59% | 12.64% | 31.14% | -3.00% | 13.26% | Upgrade
|
| Cost of Revenue | 6,128 | 5,969 | 5,060 | 4,446 | 3,407 | 3,603 | Upgrade
|
| Gross Profit | 6,473 | 6,226 | 5,138 | 4,608 | 3,496 | 3,515 | Upgrade
|
| Selling, General & Admin | 1,893 | 1,845 | 1,582 | 52.22 | 41.25 | 83.32 | Upgrade
|
| Other Operating Expenses | 980.66 | 960.43 | 848.63 | 1,978 | 1,522 | 1,747 | Upgrade
|
| Operating Expenses | 3,812 | 3,727 | 3,322 | 2,884 | 2,244 | 2,351 | Upgrade
|
| Operating Income | 2,660 | 2,499 | 1,816 | 1,724 | 1,253 | 1,163 | Upgrade
|
| Interest Expense | -289.26 | -327.5 | -399.33 | -428.66 | -306.92 | -142.5 | Upgrade
|
| Interest & Investment Income | 161.19 | 161.19 | 99.26 | 87.87 | 76.58 | 74.98 | Upgrade
|
| Other Non Operating Income (Expenses) | 36.37 | 45.92 | 58.03 | 33.24 | 33.34 | 27.25 | Upgrade
|
| EBT Excluding Unusual Items | 2,568 | 2,379 | 1,574 | 1,416 | 1,056 | 1,123 | Upgrade
|
| Gain (Loss) on Sale of Assets | -3.23 | -3.23 | -21.66 | -9.33 | 1.58 | -3.96 | Upgrade
|
| Pretax Income | 2,565 | 2,376 | 1,552 | 1,407 | 1,057 | 1,119 | Upgrade
|
| Income Tax Expense | 620.8 | 578.26 | 394.54 | 364.18 | 280.51 | 173.26 | Upgrade
|
| Net Income | 1,944 | 1,797 | 1,158 | 1,043 | 776.85 | 945.87 | Upgrade
|
| Net Income to Common | 1,944 | 1,797 | 1,158 | 1,043 | 776.85 | 945.87 | Upgrade
|
| Net Income Growth | 58.05% | 55.25% | 11.04% | 34.21% | -17.87% | 57.27% | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | 11 | Upgrade
|
| Shares Change (YoY) | 0.02% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 177.69 | 164.26 | 105.80 | 95.28 | 71.00 | 86.44 | Upgrade
|
| EPS (Diluted) | 177.69 | 164.26 | 105.80 | 95.28 | 71.00 | 86.44 | Upgrade
|
| EPS Growth | 58.02% | 55.25% | 11.04% | 34.21% | -17.87% | 57.27% | Upgrade
|
| Free Cash Flow | - | 2,057 | 1,355 | 1,625 | 48.19 | -1,139 | Upgrade
|
| Free Cash Flow Per Share | - | 188.00 | 123.85 | 148.54 | 4.40 | -104.14 | Upgrade
|
| Dividend Per Share | - | 10.000 | 5.000 | 3.000 | 3.000 | 3.000 | Upgrade
|
| Dividend Growth | - | 100.00% | 66.67% | 0% | 0% | 0% | Upgrade
|
| Gross Margin | 51.37% | 51.05% | 50.38% | 50.90% | 50.64% | 49.38% | Upgrade
|
| Operating Margin | 21.11% | 20.49% | 17.81% | 19.04% | 18.15% | 16.35% | Upgrade
|
| Profit Margin | 15.43% | 14.74% | 11.35% | 11.52% | 11.25% | 13.29% | Upgrade
|
| Free Cash Flow Margin | - | 16.87% | 13.29% | 17.95% | 0.70% | -16.01% | Upgrade
|
| EBITDA | 3,540 | 3,372 | 2,660 | 2,534 | 1,894 | 1,659 | Upgrade
|
| EBITDA Margin | 28.09% | 27.65% | 26.09% | 27.99% | 27.43% | 23.31% | Upgrade
|
| D&A For EBITDA | 879.7 | 872.6 | 844.17 | 810.78 | 640.96 | 495.54 | Upgrade
|
| EBIT | 2,660 | 2,499 | 1,816 | 1,724 | 1,253 | 1,163 | Upgrade
|
| EBIT Margin | 21.11% | 20.49% | 17.81% | 19.04% | 18.15% | 16.35% | Upgrade
|
| Effective Tax Rate | 24.20% | 24.34% | 25.42% | 25.89% | 26.53% | 15.48% | Upgrade
|
| Revenue as Reported | 12,800 | 12,405 | 10,357 | 9,178 | 7,022 | 7,223 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.